Clinical Parameters in Osteoporosis Patients Supplemented With PMA-Zeolite at the End of 5-Year Double-Blinded Clinical Trial.

Kraljevic Pavelic, Sandra; Krpan, Dalibor; Zuvic, Marta; Eisenwagen, Sandra; Pavelic, Kresimir

Kraljevic Pavelic, Sandra; Krpan, Dalibor; Zuvic, Marta; Eisenwagen, Sandra; Pavelic, Kresimir.

Afiliación

Kraljevic Pavelic S; Faculty of Health Studies, University of Rijeka, Rijeka, Croatia.
Krpan D; Polyclinic "K - centre", for Internal Medicine, Gynaecology, Radiology, Physical Medicine and Rehabilitation, Zagreb, Croatia.
Zuvic M; Department of Biotechnology, University of Rijeka, Rijeka, Croatia.
Eisenwagen S; Panaceo International GmbH, Godersdorf, Austria.
Pavelic K; Faculty of Medicine, Juraj Dobrila University of Pula, Pula, Croatia.

Front Med (Lausanne) ; 9: 870962, 2022.

Article en En | MEDLINE | ID: mdl-35833103

Palabras clave

PMA-zeolite; bone fracture; clinical trial; clinoptilolite; osteoporosis; surrogate bone metabolic markers

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Front Med (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: Croacia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google